[Elsevier] Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial |
|
This post will be closed automatically in 2026-06-29 09:11
Reward10points
|
| |
10
Firms' digitalization in manufacturing and the structure and direction of green innovation
10
Building a greener future: The promise of sustainable alkali activated material/geopolymer in construction
50
[Full book]Aminoff's Diagnosis of Neuromuscular Disorders 4th Edition
10
Palmitic acid reprograms neutrophils to compromise vascular integrity and promote breast cancer lung metastasis
30
Methotrexate toxicity pattern among Egyptian patients: Possible implications of glomerular filtration rate and methotrexate level on low-dose MTX-related toxicities
